V2X, Inc. Common Stock VVX 深 滬
等待開盤 10-02 09:30:00 美东时间
58.08
-0.010
-0.02%
華盛通- 最 高58.64
- 今 開58.09
- 成交量 34.34万股
- 最 低 57.23
- 昨 收 58.09
- 總市值 18.42亿
- 52周最高 69.75
- 市盈率 靜 53.53
- 換手率 1.08%
- 52周最低 41.075
- 委 比 81.82%
- 總股本 3170.98万
- 歷史最高 69.75
- 量 比 1.08
- 振 幅 2.43%
- 歷史最低 12.50
- 每 手 1
- 風險率 5.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多V2X Wins $84M Navy Contract To Support Safe Water Supply In Hawaii
V2X, Inc. (NYSE: VVX) announced it has been awarded an $84 million task order under the U.S. Navy's Global Contingency Services Multiple Award Contract III indefinite-delivery, indefinite-quantity. The award
10-01 19:31
V2X Completes Acquisition of QinetiQ U.S. Intelligence Business, Expanding National Security Capabilities
RESTON, Va., Sept 22, 2025 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) today announced the successful completion of its acquisition of QinetiQ's U.S. Intelligence business, a provider of data engi...
09-22 19:30
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Morgan Stanley Maintains Underweight on V2X, Raises Price Target to $55
Morgan Stanley analyst Kristine Liwag maintains V2X (NYSE:VVX) with a Underweight and raises the price target from $51 to $55.
09-20 01:14
V2X Secures Pentagon Defense Deal Worth Up To $3.5B To Fight Nuclear And Biological Risks
V2X Inc., (NYSE:VVX), has been awarded a position on the Defense Threat Reduction Agency's (DTRA) Cooperative Threat Reduction Integrating Contract IV (CTRIC IV). V2X is one of six recipients selected for this
09-18 19:33
V2X Names Greg Lundy Vice President of Technology
RESTON, Va., Sept. 8, 2025 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) today announced the appointment of Greg Lundy as Vice President of Technology, effective immediately. In this role, Lundy wil...
09-08 19:45
V2X (VVX) Gets a Buy from Noble Financial
In a report released today, Joe Gomes from Noble Financial maintained a Buy rat...
08-27 20:55
美股大行评级 | 潜在涨幅95.33%！HC Wainwright & Co.上调Insmed目标价至240美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Insmed"买入"评级，目标价从120美元升至240美元；巴克莱：维持Transocean"超配"评级，目标价从3.5美元升至4美元
08-14 09:25
Goldman Sachs Maintains Sell on V2X, Raises Price Target to $50
Goldman Sachs analyst Noah Poponak maintains V2X (NYSE:VVX) with a Sell and raises the price target from $45 to $50.
08-13 22:47
V2X Reduces Shareholder Influence After Stock Offering
V2X ( ($VVX) ) just unveiled an announcement. On August 8, 2025, V2X, Inc. ente...
08-12 05:49
